[go: up one dir, main page]

ATE290871T1 - Verfahren zur behandlung navikularer krankheiten bei pferden - Google Patents

Verfahren zur behandlung navikularer krankheiten bei pferden

Info

Publication number
ATE290871T1
ATE290871T1 AT96933368T AT96933368T ATE290871T1 AT E290871 T1 ATE290871 T1 AT E290871T1 AT 96933368 T AT96933368 T AT 96933368T AT 96933368 T AT96933368 T AT 96933368T AT E290871 T1 ATE290871 T1 AT E290871T1
Authority
AT
Austria
Prior art keywords
treating
horses
pct
compound
formula
Prior art date
Application number
AT96933368T
Other languages
English (en)
Inventor
Alan Martin Wilson
Allen Edward Goodship
Jonathan Green
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4241002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE290871(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE290871T1 publication Critical patent/ATE290871T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96933368T 1995-09-29 1996-09-24 Verfahren zur behandlung navikularer krankheiten bei pferden ATE290871T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH276095 1995-09-29
PCT/EP1996/004161 WO1997012619A1 (en) 1995-09-29 1996-09-24 Method of treating the navicular disease in horses

Publications (1)

Publication Number Publication Date
ATE290871T1 true ATE290871T1 (de) 2005-04-15

Family

ID=4241002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96933368T ATE290871T1 (de) 1995-09-29 1996-09-24 Verfahren zur behandlung navikularer krankheiten bei pferden

Country Status (9)

Country Link
US (1) US6057306A (de)
EP (1) EP0854724B1 (de)
JP (1) JPH11513383A (de)
AT (1) ATE290871T1 (de)
AU (1) AU7213196A (de)
DE (1) DE69634487T2 (de)
ES (1) ES2239774T3 (de)
PT (1) PT854724E (de)
WO (1) WO1997012619A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784031B1 (fr) 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
US6794536B1 (en) * 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
ATE304856T1 (de) 2000-06-20 2005-10-15 Novartis Pharma Gmbh Methode zur verabreichung von biphosphonaten
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
EP1482897A2 (de) * 2002-02-19 2004-12-08 Ilex Products, Inc. Aminodiphosphonat-apolipoprotein-e-modulatoren
US7358361B2 (en) * 2004-10-08 2008-04-15 The Board Of Trustees Of The University Of Illinois Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
US7687482B2 (en) * 2006-03-17 2010-03-30 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
WO2008128056A1 (en) * 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
DE102005053512A1 (de) * 2005-11-09 2007-06-28 Omnimedic Gbr Verwendung von Clodronsäure zur Behandlung von Podotrochlose
FR2926081B1 (fr) 2008-01-03 2010-02-19 Univ Nantes Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux
US20110118243A1 (en) * 2008-03-20 2011-05-19 Lynn Chambers Anti-inflammatory drug delivery system
CN105924470B (zh) * 2016-07-11 2019-01-29 成都云克药业有限责任公司 一种二膦酸化合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130794C3 (de) * 1971-06-22 1974-07-11 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
DE3428524A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3770982D1 (de) * 1986-04-24 1991-08-01 Fujisawa Pharmaceutical Co Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5057505A (en) * 1986-11-21 1991-10-15 Ciba-Geigy Corporation Substituted aminomethanediphosphonic acids and use in medicaments
EP0274346B1 (de) * 1986-11-21 1991-03-06 Ciba-Geigy Ag Neue Substituiertaminomethandiphosphonsäuren
EP0275821B1 (de) * 1986-11-21 1992-02-26 Ciba-Geigy Ag Neue substituierte Alkandiphosphonsäuren
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use

Also Published As

Publication number Publication date
EP0854724B1 (de) 2005-03-16
EP0854724A1 (de) 1998-07-29
DE69634487T2 (de) 2006-01-05
JPH11513383A (ja) 1999-11-16
US6057306A (en) 2000-05-02
DE69634487D1 (de) 2005-04-21
AU7213196A (en) 1997-04-28
PT854724E (pt) 2005-08-31
WO1997012619A1 (en) 1997-04-10
ES2239774T3 (es) 2005-10-01

Similar Documents

Publication Publication Date Title
GB9408577D0 (en) New compound
FI971967A0 (fi) Dioksomorfoliinien käyttö sisäloisten torjuntaan, uusia dioksomorfiineja ja menetelmä niiden valmistamiseksi
ATE290871T1 (de) Verfahren zur behandlung navikularer krankheiten bei pferden
ATE179976T1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
DE69404039D1 (de) Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit
BR9609888A (pt) Halogenobenzimidazóis
DE69833971D1 (de) Verfahren zur behandlung von alzheimerschen krankheit
ES2173172T3 (es) Derivados de 1,3-dihidroindol-2-ona sustituidos en 3 por un grupo nitrogenado como agonistas y/o antagonistas de la vasopresina y/o de la octocina.
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
ATE212834T1 (de) 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz
BR9508295A (pt) Utilização de compostos de tiazol e tiadiazol composto composição farmacêutica e processos para preparar um composto e tratar distúrbios que respondem a ligantes de receptor d3 de dopamina
NO970161D0 (no) Triazolforbindelser og anvendelse derav
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
ATE252897T1 (de) Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen
NO980163D0 (no) Renset, varmekoagulert potetprotein for anvendelse i dyrefôr
ATE326964T1 (de) Aminosäurederivate zur behandlung der alzheimer- krankheit
ATE123773T1 (de) 1,3,5-triazin-2,4,6-tris- alkylaminocarbonsäureaminoester, diese enthaltende biozide mittel sowie verfahren zu ihrer herstellung.
DE69127285D1 (de) Verwendung von verbindungen zur behandlung von altersbedingtem gedächtnisschwund und anderen kognitiven störungen
ATE214375T1 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
DE69626301D1 (de) Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen
NO306670B1 (no) FremgangsmÕte for fremstilling av 3,4-dihydroksy-5-nitrobenzaldehyd
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
ATE204872T1 (de) Verfahren zur herstellung von anhydroecgonin- estern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0854724

Country of ref document: EP